US Stock MarketDetailed Quotes

ACRS Aclaris Therapeutics

Watchlist
  • 1.320
  • +0.010+0.76%
Close Jul 19 16:00 ET
  • 1.302
  • -0.018-1.36%
Post 19:39 ET
94.07MMarket Cap-1211P/E (TTM)

Aclaris Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
21.01%-20.82M
-15.92%-78.33M
64.63%-6.76M
-214.15%-24.56M
-5.02%-20.65M
-25.68%-26.35M
-29.60%-67.57M
-11.95%-19.12M
26.30%-7.82M
-60.92%-19.67M
Net income from continuing operations
39.84%-16.94M
-1.81%-88.48M
94.60%-1.49M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
4.35%-86.91M
-21.18%-27.64M
5.65%-19.95M
-13.06%-20.53M
Depreciation and amortization
22.73%243K
8.28%863K
20.00%228K
13.47%219K
5.83%218K
-4.81%198K
-13.65%797K
-3.55%190K
1.05%193K
-16.60%206K
Deferred tax
----
---367K
----
----
----
----
--0
----
----
----
Other non cash items
450.00%2.8M
-672.34%-26.9M
-470.42%-26.3M
-22.73%1.7M
55.88%-1.5M
33.33%-800K
-80.69%4.7M
222.73%7.1M
144.44%2.2M
-170.83%-3.4M
Change In working capital
-104.82%-9.01M
885.69%9.39M
470.47%13.27M
-156.95%-3.16M
898.64%3.68M
-24.42%-4.4M
11.02%-1.2M
-590.37%-3.58M
11.19%5.55M
112.52%368K
-Change in receivables
62.87%-75K
33.81%186K
-57.52%48K
112.50%85K
6,475.00%255K
-1,920.00%-202K
-6.71%139K
-39.89%113K
-68.75%40K
96.72%-4K
-Change in prepaid assets
333.87%2.04M
42.68%-1.32M
239.92%7.98M
-466.27%-7.69M
-165.21%-731K
-564.89%-874K
59.16%-2.29M
-1.66%-5.7M
-59.75%2.1M
137.71%1.12M
-Change in payables and accrued expense
-230.47%-10.98M
995.63%10.52M
161.62%5.25M
30.01%4.44M
654.21%4.15M
10.53%-3.32M
-76.73%960K
-59.08%2.01M
1,081.32%3.42M
-580.13%-749K
Cash from discontinued investing activities
Operating cash flow
21.01%-20.82M
-15.92%-78.33M
64.63%-6.76M
-214.15%-24.56M
-5.02%-20.65M
-25.68%-26.35M
-29.60%-67.57M
-11.95%-19.12M
26.30%-7.82M
-60.92%-19.67M
Investing cash flow
Cash flow from continuing investing activities
-34.75%16.83M
266.01%46.22M
179.42%7.55M
2,573.29%32.53M
7.36%-19.66M
-13.81%25.8M
107.53%12.63M
129.45%2.7M
103.23%1.22M
53.33%-21.22M
Net PPE purchase and sale
75.59%-135K
-116.36%-1.31M
-320.00%-441K
44.00%-84K
-24.19%-231K
-237.20%-553K
-96.43%-605K
47.50%-105K
-167.86%-150K
-257.69%-186K
Net investment purchase and sale
-35.61%16.97M
259.17%47.53M
184.68%7.99M
2,286.10%32.62M
7.63%-19.43M
-12.44%26.35M
107.91%13.23M
131.27%2.81M
103.63%1.37M
53.68%-21.04M
Cash from discontinued investing activities
Investing cash flow
-34.75%16.83M
266.01%46.22M
179.42%7.55M
2,573.29%32.53M
7.36%-19.66M
-13.81%25.8M
107.53%12.63M
129.45%2.7M
103.23%1.22M
53.33%-21.22M
Financing cash flow
Cash flow from continuing financing activities
-55K
-63.35%26.71M
32.43%49K
-690.91%-87K
-63.27%26.74M
0
-67.62%72.87M
1,950.00%37K
99.90%-11K
-46.41%72.81M
Net issuance payments of debt
----
--0
----
----
----
----
--0
----
----
----
Net common stock issuance
----
-63.28%26.71M
--0
--0
----
----
-69.46%72.74M
--0
--0
----
Proceeds from stock option exercised by employees
----
-40.13%94K
32.43%49K
--15K
----
----
-89.24%157K
--37K
--0
-92.04%83K
Net other financing activities
---55K
-200.00%-102K
--0
----
----
----
98.91%-34K
--0
86.90%-11K
33.33%-16K
Cash from discontinued financing activities
Financing cash flow
---55K
-63.35%26.71M
32.43%49K
-690.91%-87K
-63.27%26.74M
--0
-67.62%72.87M
1,950.00%37K
99.90%-11K
-46.41%72.81M
Net cash flow
Beginning cash position
-11.92%39.88M
65.55%45.28M
-36.68%39.04M
-54.37%31.15M
23.06%44.72M
65.55%45.28M
23.96%27.35M
15.02%61.65M
-39.83%68.26M
3.05%36.34M
Current changes in cash
-627.39%-4.04M
-130.11%-5.4M
105.12%838K
219.35%7.89M
-142.52%-13.57M
-106.17%-555K
239.16%17.93M
37.62%-16.38M
88.95%-6.61M
-59.17%31.92M
End cash Position
-19.86%35.84M
-11.92%39.88M
-11.92%39.88M
-36.68%39.04M
-54.37%31.15M
23.06%44.72M
65.55%45.28M
65.55%45.28M
15.02%61.65M
-39.83%68.26M
Free cash flow
22.14%-20.95M
-16.81%-79.63M
62.53%-7.2M
-209.29%-24.64M
-5.20%-20.89M
-27.32%-26.91M
-30.00%-68.17M
-11.26%-19.22M
25.28%-7.97M
-61.75%-19.85M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 21.01%-20.82M-15.92%-78.33M64.63%-6.76M-214.15%-24.56M-5.02%-20.65M-25.68%-26.35M-29.60%-67.57M-11.95%-19.12M26.30%-7.82M-60.92%-19.67M
Net income from continuing operations 39.84%-16.94M-1.81%-88.48M94.60%-1.49M-46.66%-29.26M-44.01%-29.57M-49.87%-28.16M4.35%-86.91M-21.18%-27.64M5.65%-19.95M-13.06%-20.53M
Depreciation and amortization 22.73%243K8.28%863K20.00%228K13.47%219K5.83%218K-4.81%198K-13.65%797K-3.55%190K1.05%193K-16.60%206K
Deferred tax -------367K------------------0------------
Other non cash items 450.00%2.8M-672.34%-26.9M-470.42%-26.3M-22.73%1.7M55.88%-1.5M33.33%-800K-80.69%4.7M222.73%7.1M144.44%2.2M-170.83%-3.4M
Change In working capital -104.82%-9.01M885.69%9.39M470.47%13.27M-156.95%-3.16M898.64%3.68M-24.42%-4.4M11.02%-1.2M-590.37%-3.58M11.19%5.55M112.52%368K
-Change in receivables 62.87%-75K33.81%186K-57.52%48K112.50%85K6,475.00%255K-1,920.00%-202K-6.71%139K-39.89%113K-68.75%40K96.72%-4K
-Change in prepaid assets 333.87%2.04M42.68%-1.32M239.92%7.98M-466.27%-7.69M-165.21%-731K-564.89%-874K59.16%-2.29M-1.66%-5.7M-59.75%2.1M137.71%1.12M
-Change in payables and accrued expense -230.47%-10.98M995.63%10.52M161.62%5.25M30.01%4.44M654.21%4.15M10.53%-3.32M-76.73%960K-59.08%2.01M1,081.32%3.42M-580.13%-749K
Cash from discontinued investing activities
Operating cash flow 21.01%-20.82M-15.92%-78.33M64.63%-6.76M-214.15%-24.56M-5.02%-20.65M-25.68%-26.35M-29.60%-67.57M-11.95%-19.12M26.30%-7.82M-60.92%-19.67M
Investing cash flow
Cash flow from continuing investing activities -34.75%16.83M266.01%46.22M179.42%7.55M2,573.29%32.53M7.36%-19.66M-13.81%25.8M107.53%12.63M129.45%2.7M103.23%1.22M53.33%-21.22M
Net PPE purchase and sale 75.59%-135K-116.36%-1.31M-320.00%-441K44.00%-84K-24.19%-231K-237.20%-553K-96.43%-605K47.50%-105K-167.86%-150K-257.69%-186K
Net investment purchase and sale -35.61%16.97M259.17%47.53M184.68%7.99M2,286.10%32.62M7.63%-19.43M-12.44%26.35M107.91%13.23M131.27%2.81M103.63%1.37M53.68%-21.04M
Cash from discontinued investing activities
Investing cash flow -34.75%16.83M266.01%46.22M179.42%7.55M2,573.29%32.53M7.36%-19.66M-13.81%25.8M107.53%12.63M129.45%2.7M103.23%1.22M53.33%-21.22M
Financing cash flow
Cash flow from continuing financing activities -55K-63.35%26.71M32.43%49K-690.91%-87K-63.27%26.74M0-67.62%72.87M1,950.00%37K99.90%-11K-46.41%72.81M
Net issuance payments of debt ------0------------------0------------
Net common stock issuance -----63.28%26.71M--0--0---------69.46%72.74M--0--0----
Proceeds from stock option exercised by employees -----40.13%94K32.43%49K--15K---------89.24%157K--37K--0-92.04%83K
Net other financing activities ---55K-200.00%-102K--0------------98.91%-34K--086.90%-11K33.33%-16K
Cash from discontinued financing activities
Financing cash flow ---55K-63.35%26.71M32.43%49K-690.91%-87K-63.27%26.74M--0-67.62%72.87M1,950.00%37K99.90%-11K-46.41%72.81M
Net cash flow
Beginning cash position -11.92%39.88M65.55%45.28M-36.68%39.04M-54.37%31.15M23.06%44.72M65.55%45.28M23.96%27.35M15.02%61.65M-39.83%68.26M3.05%36.34M
Current changes in cash -627.39%-4.04M-130.11%-5.4M105.12%838K219.35%7.89M-142.52%-13.57M-106.17%-555K239.16%17.93M37.62%-16.38M88.95%-6.61M-59.17%31.92M
End cash Position -19.86%35.84M-11.92%39.88M-11.92%39.88M-36.68%39.04M-54.37%31.15M23.06%44.72M65.55%45.28M65.55%45.28M15.02%61.65M-39.83%68.26M
Free cash flow 22.14%-20.95M-16.81%-79.63M62.53%-7.2M-209.29%-24.64M-5.20%-20.89M-27.32%-26.91M-30.00%-68.17M-11.26%-19.22M25.28%-7.97M-61.75%-19.85M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg